- API
autism prevalence studies
data.cdc.gov | Last Updated 2023-05-02T17:46:55.000ZThis data table provides a collection of information from peer-reviewed autism prevalence studies. Information reported from each study includes the autism prevalence estimate and additional study characteristics (e.g., case ascertainment and criteria). A PubMed search was conducted to identify studies published at any time through September 2020 using the search terms: autism (title/abstract) OR autistic (title/abstract) AND prevalence (title/abstract). Data were abstracted and included if the study fulfilled the following criteria: • The study was published in English; • The study produced at least one autism prevalence estimate; and • The study was population-based (any age range) within a defined geographic area.
- API
Early Model-based Provisional Estimates of Drug Overdose, Suicide, and Transportation-related Deaths
data.cdc.gov | Last Updated 2022-03-30T16:02:45.000ZThis dataset provides model-based provisional estimates of the weekly numbers of drug overdose, suicide, and transportation-related deaths using “nowcasting” methods to account for the normal lag between the occurrence and reporting of these deaths. Estimates less than 10 are suppressed. These early model-based provisional estimates were generated using a multi-stage hierarchical Bayesian modeling process to generate smoothed estimates of the weekly numbers of death, accounting for reporting lags. These estimates are based on several assumptions about how the reporting lags have changed in recent months across different jurisdictions, and the resulting estimates differ from other sources of provisional mortality data. For now, these estimates should be considered highly uncertain until further evaluations can be done to determine the validity of these assumptions about timeliness. The true patterns in reporting lags will not be known until data are finalized, typically 11–12 months after the end of the calendar year. Importantly, these estimates are not a replacement for monthly provisional drug overdose death counts, or quarterly provisional mortality estimates. For more detail about the nowcasting methods and models, see: Rossen LM, Hedegaard H, Warner M, Ahmad FB, Sutton PD. Early provisional estimates of drug overdose, suicide, and transportation-related deaths: Nowcasting methods to account for reporting lags. Vital Statistics Rapid Release; no 11. Hyattsville, MD: National Center for Health Statistics. February 2021. DOI: https://doi.org/10.15620/ cdc:101132
- API
Vaccination Coverage and Exemptions among Kindergartners
data.cdc.gov | Last Updated 2024-05-24T18:03:21.000ZVaccination Coverage and Exemptions among Kindergartners • Data on school vaccination coverage and exemptions from the School Vaccination Assessment Program for kindergartners at the national and state levels. • Additional information available at https://www.cdc.gov/vaccines/imz-managers/coverage/schoolvaxview/index.html
- API
NCHS - Childhood Mortality Rates
data.cdc.gov | Last Updated 2022-04-01T18:36:17.000ZThis dataset of U.S. mortality trends since 1900 highlights childhood mortality rates by age group for age at death. Age-adjusted death rates (deaths per 100,000) after 1998 are calculated based on the 2000 U.S. standard population. Populations used for computing death rates for 2011–2017 are postcensal estimates based on the 2010 census, estimated as of July 1, 2010. Rates for census years are based on populations enumerated in the corresponding censuses. Rates for noncensus years between 2000 and 2010 are revised using updated intercensal population estimates and may differ from rates previously published. Data on age-adjusted death rates prior to 1999 are taken from historical data (see References below). Age groups for childhood death rates are based on age at death. SOURCES CDC/NCHS, National Vital Statistics System, historical data, 1900-1998 (see https://www.cdc.gov/nchs/nvss/mortality_historical_data.htm); CDC/NCHS, National Vital Statistics System, mortality data (see http://www.cdc.gov/nchs/deaths.htm); and CDC WONDER (see http://wonder.cdc.gov). REFERENCES 1. National Center for Health Statistics, Data Warehouse. Comparability of cause-of-death between ICD revisions. 2008. Available from: http://www.cdc.gov/nchs/nvss/mortality/comparability_icd.htm. 2. National Center for Health Statistics. Vital statistics data available. Mortality multiple cause files. Hyattsville, MD: National Center for Health Statistics. Available from: https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm. 3. Kochanek KD, Murphy SL, Xu JQ, Arias E. Deaths: Final data for 2017. National Vital Statistics Reports; vol 68 no 9. Hyattsville, MD: National Center for Health Statistics. 2019. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_09-508.pdf. 4. Arias E, Xu JQ. United States life tables, 2017. National Vital Statistics Reports; vol 68 no 7. Hyattsville, MD: National Center for Health Statistics. 2019. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_07-508.pdf. 5. National Center for Health Statistics. Historical Data, 1900-1998. 2009. Available from: https://www.cdc.gov/nchs/nvss/mortality_historical_data.htm.
- API
Botswana Combination Prevention Project (BCPP) - Public Release Data
data.cdc.gov | Last Updated 2022-05-24T12:45:57.000ZThe Botswana Combination Prevention Project (BCPP) was a research project conducted by the Botswana Ministry of Health (MOH), Harvard School of Public Health/Botswana Harvard AIDS Institute Partnership (BHP), and the U.S. Centers for Disease Control and Prevention (CDC). BCPP was a community randomized trial that examined the impact of prevention interventions on HIV incidence in 15 intervention and 15 control communities. The interventions included extensive HIV testing, linkage to care, and universal treatment services. To reduce HIV incidence in the intervention communities, the UNAIDS 90-90-90 goals were used: 90% of HIV-positive persons know their status; 90% of persons who know status are to be on ART; 90% of persons on ART are to be virally suppressed. The BCPP study is composed of 2 interlocking protocols: Evaluation Protocol and Intervention Protocol. The Evaluation Protocol of the BCPP evaluated the primary endpoint (HIV incidence), as well as some key related secondary endpoints. This protocol focused on the Baseline Household Survey; the HIV Incidence Cohort; and an End of Study Survey. The Intervention Protocol of the BCPP implemented the combination prevention (CP) intervention package in CPCs and measures the uptake of these interventions (expanded HIV testing and counselling, strengthened male circumcision, and expanded HIV Care and Treatment).
- API
Tests for antibodies to trachoma PGP3 antigen
data.cdc.gov | Last Updated 2019-03-14T15:55:23.000ZThis set includes data used in a latent class model to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3. The analysis was published as: Latent class modeling to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3. Wiegand RE, Cooley G, Goodhew B, Banniettis N, Kohlhoff S, Gwyn S, Martin DL. Sci Rep. 2018 Mar 9;8(1):4232. doi: 10.1038/s41598-018-22708-9. PMID: 29523810
- API
Percentage of Drivers & Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Bar Chart
data.cdc.gov | Last Updated 2016-09-27T17:57:40.000ZSource for 2012 national data: National Occupant Protection Use Survey (NOPUS), 2012. Source for 2012 state data: State Observational Survey of Seat Belt Use, 2012. Source for 2014 national data: National Highway Traffic Safety Administration's (NHTSA) National Occupant Protection Use Survey (NOPUS), 2014. Source for 2014 state data: National Highway Traffic Safety Administration's (NHTSA) State Observation of Seat Belt Use, 2014
- API
Healthy People 2020 Final Progress Table
data.cdc.gov | Last Updated 2023-08-23T19:39:25.000Z[1] Status is determined using the baseline, final, and target value. The statuses used in Healthy People 2020 were: 1 - Target met or exceeded—One of the following applies: (i) At baseline, the target was not met or exceeded, and the most recent value was equal to or exceeded the target. (The percentage of targeted change achieved was equal to or greater than 100%.); (ii) The baseline and most recent values were equal to or exceeded the target. (The percentage of targeted change achieved was not assessed.) 2 - Improved—One of the following applies: (i) Movement was toward the target, standard errors were available, and the percentage of targeted change achieved was statistically significant; (ii) Movement was toward the target, standard errors were not available, and the objective had achieved 10% or more of the targeted change. 3 - Little or no detectable change—One of the following applies: (i) Movement was toward the target, standard errors were available, and the percentage of targeted change achieved was not statistically significant; (ii) Movement was toward the target, standard errors were not available, and the objective had achieved less than 10% of the targeted change; (iii) Movement was away from the baseline and target, standard errors were available, and the percent change relative to the baseline was not statistically significant; (iv) Movement was away from the baseline and target, standard errors were not available, and the objective had moved less than 10% relative to the baseline; (v) No change was observed between the baseline and the final data point. 4 - Got worse—One of the following applies: (i) Movement was away from the baseline and target, standard errors were available, and the percent change relative to the baseline was statistically significant; (ii) Movement was away from the baseline and target, standard errors were not available, and the objective had moved 10% or more relative to the baseline. 5 - Baseline only—The objective only had one data point, so progress toward target attainment could not be assessed. Note that if additional data points did not meet the criteria for statistical reliability, data quality, or confidentiality, the objective was categorized as baseline only. 6 - Informational—A target was not set for this objective, so progress toward target attainment could not be assessed. [2] The final value is generally based on data available on the Healthy People 2020 website as of January 2020. For objectives that are continuing into Healthy People 2030, more recent data are available on the Healthy People 2030 website: https://health.gov/healthypeople. [3] For objectives that moved toward their targets, movement toward the target was measured as the percentage of targeted change achieved (unless the target was already met or exceeded at baseline): Percentage of targeted change achieved = (Final value - Baseline value) / (HP2020 target - Baseline value) * 100 [4] For objectives that were not improving, did not meet or exceed their targets, and did not move towards their targets, movement away from the baseline was measured as the magnitude of the percent change from baseline: Magnitude of percent change from baseline = |Final value - Baseline value| / Baseline value * 100 [5] Statistical significance was tested when the objective had a target, at least two data points (of unequal value), and available standard errors of the data. A normal distribution was assumed. All available digits were used to test statistical significance. Statistical significance of the percentage of targeted change achieved or the magnitude of the percentage change from baseline was assessed at the 0.05 level using a normal one-sided test. [6] For more information on the Healthy People 2020 methodology for measuring progress toward target attainment and the elimination of health disparities, see: Healthy People Statistical Notes, no 27; available from: https://www.cdc.gov/nchs/data/sta
- API
NCHS - Leading Causes of Death: United States
data.cdc.gov | Last Updated 2022-03-30T14:26:37.000ZThis dataset presents the age-adjusted death rates for the 10 leading causes of death in the United States beginning in 1999. Data are based on information from all resident death certificates filed in the 50 states and the District of Columbia using demographic and medical characteristics. Age-adjusted death rates (per 100,000 population) are based on the 2000 U.S. standard population. Populations used for computing death rates after 2010 are postcensal estimates based on the 2010 census, estimated as of July 1, 2010. Rates for census years are based on populations enumerated in the corresponding censuses. Rates for non-census years before 2010 are revised using updated intercensal population estimates and may differ from rates previously published. Causes of death classified by the International Classification of Diseases, Tenth Revision (ICD–10) are ranked according to the number of deaths assigned to rankable causes. Cause of death statistics are based on the underlying cause of death. SOURCES CDC/NCHS, National Vital Statistics System, mortality data (see http://www.cdc.gov/nchs/deaths.htm); and CDC WONDER (see http://wonder.cdc.gov). REFERENCES 1. National Center for Health Statistics. Vital statistics data available. Mortality multiple cause files. Hyattsville, MD: National Center for Health Statistics. Available from: https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm. 2. Murphy SL, Xu JQ, Kochanek KD, Curtin SC, and Arias E. Deaths: Final data for 2015. National vital statistics reports; vol 66. no. 6. Hyattsville, MD: National Center for Health Statistics. 2017. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr66/nvsr66_06.pdf.
- API
Influenza Vaccination Coverage for All Ages (6+ Months)
data.cdc.gov | Last Updated 2023-09-28T16:08:58.000ZInfluenza Vaccination Coverage for All Ages (6+ Months) • Data on influenza vaccination coverage from the National Immunization Survey-Flu (NIS-Flu) and the Behavioral Risk Factor Surveillance System (BRFSS) for the general population at the national, regional, and state levels by age group and race/ethnicity. • Additional information available at https://www.cdc.gov/flu/fluvaxview/index.htm